Proteomic Biomarker Identification in Age-Related Macular Degeneration, Diabetic Retinopathy and Retinal Detachment
Recruiting
N/A
Interventional Study
Age-Related Macular Degeneration (AMD)
Diabetic Retinopathy (DR)
Retinal Detachment
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 260 (estimated)
- Sponsor
- Fondazione G.B. Bietti, IRCCS · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This prospective interventional translational study aims to identify and validate protein biomarkers associated with major ophthalmological diseases, including age-related macular degeneration, diabetic retinopathy (DR), and retinal detachment (RD). A total of approximately 260 participants (cases and controls) will be enrolled at a single center.
Biological samples, including peripheral blood, t…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 18 years
* Ability to understand the study procedures and provide written informed consent
* Willingness and ability to comply with study procedures and visits
For case subjects:
* Patients with age-related macular degeneration (intermediate or advanced, including geog…
Contacts